DiaMedica Therapeutics (DMAC) Free Cash Flow (2018 - 2019)
Historic Free Cash Flow for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to -$1.9 million.
- DiaMedica Therapeutics' Free Cash Flow rose 42.4% to -$1.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$9.1 million, marking a year-over-year decrease of 5864.95%. This contributed to the annual value of -$22.1 million for FY2024, which is 1798.74% down from last year.
- Latest data reveals that DiaMedica Therapeutics reported Free Cash Flow of -$1.9 million as of Q4 2019, which was up 42.4% from -$1.2 million recorded in Q3 2019.
- DiaMedica Therapeutics' Free Cash Flow's 5-year high stood at -$967000.0 during Q1 2018, with a 5-year trough of -$3.1 million in Q1 2019.